Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromesTicagrelor vs. Clopidogrel bei akutem Koronarsyndrom ohne ST-Hebung

被引:0
|
作者
Q. Ren
C. Ren
X. Liu
C. Dong
X. Zhang
机构
[1] Shandong Provincial Hospital affiliated to Shandong University,Department of Cardiology
[2] Jining No. 1 People’s Hospital,Department of Cardiology
[3] Jining,undefined
来源
Herz | 2016年 / 41卷
关键词
Coronary artery disease; Ticagrelor; Clopidogrel; Bradyarrhythmia; Non-ST-segment MI; Koronare Herzkrankheit; Ticagrelor; Clopidogrel; Bradyarrhythmie; Nicht-ST-Hebungs-Infarkt;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:246 / 249
页数:3
相关论文
共 50 条
  • [21] Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan
    Lee, Chih-Kuo
    Wang, Tzung-Dau
    Juang, Hsiao-Ting
    Chang, Shu-Chen
    Pan, Heng-Yu
    Lin, Donna Shu-Han
    Chang, Chee-Jen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel
    Olson, W. H.
    Ma, Y. -W.
    Laliberte, F.
    Lefebvre, P.
    Crivera, C.
    Schein, J. R.
    Fields, L. E.
    Dea, K.
    Germain, G.
    Lynch, S. M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (06) : 663 - 672
  • [23] Outcomes in Women vs. Men After Non-ST-Elevation Acute Coronary Syndromes: Insights From the TIMI Trials.
    Sarma, Amy A.
    Braunwald, Eugene
    Cannon, Christopher P.
    Guo, Jianping
    Im, KyungAh
    Antman, Elliott M.
    Gibson, C. M.
    Giugliano, Robert P.
    Morrow, David A.
    Wiviott, Stephen D.
    Marc, S.
    O'Donoghue, Michelle L.
    CIRCULATION, 2018, 138
  • [24] Clopidogrel in acute coronary syndromes with non-ST elevation - Response
    Segura, VV
    REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (04): : 453 - 454
  • [25] Clopidogrel in non-ST-segment elevation acute coronary syndromes
    Mehta, Shamir R.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0G) : G25 - G30
  • [26] Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCIFindings from a National, multicenter registry
    Can Zhou
    Minghui Zhang
    Zixu Zhao
    Enze Li
    Yichen Zhao
    Wei Luo
    Keyang Zheng
    Yu Liu
    Chengqian Yin
    Xinyong Zhang
    Hai Gao
    Dong Zhao
    Changsheng Ma
    Thrombosis Journal, 23 (1)
  • [27] Both ticlopidine and clopidogrel prevent acute phase elevation of von Willebrand factor in non-ST-elevation acute coronary syndromes
    Slavina, NN
    Averkov, OV
    Gratsiansky, NA
    EUROPEAN HEART JOURNAL, 2003, 24 : 119 - 119
  • [28] Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
    Xi, Ziwei
    Li, Jianan
    Qiu, Hong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Dou, Kefei
    Xu, Bo
    Wu, Yongjian
    Qiao, Shubin
    Yang, Weixian
    Yang, Yuejin
    Gao, Runlin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [29] Comparison of platelet inhibition in patients with ST-elevation myocardial infarction vs. non-ST elevation myocardial infarction after a loading dose of swallowed vs. chewed ticagrelor
    Chernomordik, F.
    Asher, E.
    Tal, S.
    Fefer, P.
    Segev, A.
    Beigel, R.
    Matetzky, S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1236 - 1236
  • [30] Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management
    Kelham, Matthew
    Vyas, Rohan
    Ramaseshan, Rohini
    Rathod, Krishnaraj
    de Winter, Robbert J.
    de Winter, Ruben W.
    Bendz, Bjorn
    Thiele, Holger
    Hirlekar, Geir
    Morici, Nuccia
    Myat, Aung
    Michalis, Lampros K.
    Sanchis, Juan
    Kunadian, Vijay
    Berry, Colin
    Mathur, Anthony
    Jones, Daniel A.
    EUROPEAN HEART JOURNAL, 2024, 45 (27) : 2380 - 2391